Stock daily read

What happened with TDOC today?

Why it moved
Explains possible causes using the day’s news and filings
Moving with the market?
Uses market moves and trading volume to assess what drove the change
What to watch next
The next thing that could change the call, and what to look for

No read yet

Uses news and trading volume to explain the day’s move and how it relates to the market.

Investment outlook

TDOC in three months: buy, wait or sell?

Stop guessing. Get the call, a three-month target price, the best and worst cases, and a source for every claim.

In the report
  • Buy / Wait / Sell rating
  • 3-month target price
  • Bear · Base · Bull
  • vs. the market

Company

Company overview

Employers and health plans buy Teladoc Health’s Integrated Care services so members can receive medical care remotely, including primary care, mental healthcare and chronic-condition management. This segment brings in most of the company’s revenue. Clients generally pay monthly fees based on enrolled members, rather than paying only when someone seeks care; some arrangements also charge per visit. Most Integrated Care revenue comes from clients buying employee healthcare through benefit plans.

BetterHelp is the other substantial business. It connects individuals with therapists for online counseling and therapy. Users pay out of pocket or use insurance coverage, most commonly paying weekly or monthly fees for access.

Revenue depends on clients renewing contracts and maintaining covered populations, and on BetterHelp attracting and retaining paying users. A small group of large clients supplies a substantial share of revenue, particularly in Integrated Care.

In the United States, Teladoc relies on affiliated, physician-owned professional entities that it does not own to deliver care. Those entities retain control over medical practice. State rules limiting corporate control of medicine and fee splitting shape these arrangements and can require changes to how Teladoc operates.

Read allShow less
Source: SEC filing

Red flags

Know what’s buried in TDOC’s filings before you buy

The risk section is the longest, dullest part of the filing. This keeps only what can really hurt you: where it hits, how hard, when it plays out.

Sorted into
  • Happening now
  • Could go wrong
  • Built in

Moat

TDOC says it has a moat. Does it hold up?

Every company claims an edge. Each one is checked against hard numbers like margins and returns: which hold, and which line gives way first.

Each edge rated
  • Strong
  • Moderate
  • Limited
  • Unproven

Related companies

  • Competition
  • Shared drivers
  • Supplier
  • Customer

Teladoc also depends on BetterHelp winning and retaining therapy users against rivals such as Talkspace and Spring Health, neither of which appears in this list.

  • American Well competes with Teladoc for health plans and hospital systems that pay for virtual-care services and platforms. Watch subscriptions to its Amwell Platform for a read on demand in the institutional market Teladoc also serves.

  • Omada Health competes with Teladoc for employer and health-plan contracts that pay for members’ digital chronic-condition care. Its diabetes and hypertension programs are worth watching for competition facing Teladoc’s chronic-care access-fee business.

  • DarioHealth competes with Teladoc to sell digital chronic-care and behavioral-health programs to employers and health plans. Watch the prices those customers pay per member or per engaged member each month for signs of pricing pressure in this shared market.

  • Hims & Hers Health overlaps with Teladoc in consumer-paid virtual mental healthcare, but emphasizes prescriptions while Teladoc’s BetterHelp emphasizes counseling and therapy. Its mental-health offering is the relevant comparison for BetterHelp, rather than its broader prescription business.

  • LifeMD overlaps with Teladoc in subscription-based virtual primary care, though LifeMD leans toward consumer specialty treatments and accepts cash payments or insurance reimbursement, while Teladoc mainly sells Integrated Care to organizations. Watch LifeMD+ primary-care subscriptions rather than its specialty-treatment business for the closer comparison.

  • Hinge Health draws on the same employer and health-plan spending that funds Teladoc’s Integrated Care, selling digital muscle-and-joint care rather than Teladoc’s broader virtual services. Its contracts with self-insured employers are worth watching for appetite to fund digital care benefits intended to reduce medical costs.

Agenda

in 8 daysWed, Oct 28

  1. Time to be announced
    Major

    Teladoc Health, Inc. earningsThis company

    Teladoc’s report will show whether organizational clients are sustaining recurring Integrated Care revenue and whether BetterHelp is keeping its paying users.

in 13 daysMon, Nov 2

  1. Time to be announced

    Hinge Health, Inc. earningsHNGE

    Hinge Health’s report will show whether employers are still paying for digital muscle-and-joint care, a read on the employer demand Teladoc’s Integrated Care also relies on.

in 14 daysTue, Nov 3

  1. Time to be announced

    American Well Corporation earningsAMWL

    American Well’s report will show health plans’ and hospitals’ demand for its virtual-care platform, a read on the institutional market Teladoc also serves.

in 16 daysThu, Nov 5

  1. Time to be announced

    Omada Health, Inc. earningsOMDA

    Omada Health’s report will show employer and health-plan demand for digital chronic-care programs, a read on competition for Teladoc’s chronic-care business.

in 20 daysMon, Nov 9

  1. Time to be announced

    Hims & Hers Health, Inc. earningsHIMS

    Hims & Hers Health’s report will show demand for its consumer mental-health offering, a comparison for BetterHelp as it competes for online mental-health users.

in 23 daysThu, Nov 12

  1. Time to be announced

    DarioHealth Corp. earningsDRIO

    DarioHealth’s report will show what employers and health plans pay per member for digital chronic-care and behavioral-health programs, a read on pricing pressure in a market relevant to Teladoc’s access-fee business.